title: Regulation of growth-regulated oncogene alpha expression by estrogen in human endothelial cells.
abstract: OBJECTIVE
  To study the effect of estrogen on expression of growth-regulated oncogene alpha (GROalpha) in human umbilical vein endothelial cells (HUVEC) in vitro.
  
  
  METHODS
  Expressions of CXC chemokine GROalpha mRNA and protein were measured by Northern blotting assay and ELISA, respectively. The physiological significance of GROalpha expression was tested by static cell adhesion assay.
  
  
  RESULTS
  Both the GROalpha mRNA and protein levels decreased markedly after HUVEC were exposured to 17beta-estradiol (2 0.05 micromol/L. Moreover, the inhibition of the protein was depended on the concentration of 17beta-estradiol. Tamoxifen (0.1 micromol/L), an estrogen receptor alpha antagonist, alone did not affect GROalpha protein expression, but can reverse the E2 -induced inhibition of GROalpha protein expression (by up to 50 %) and the binding of U937 cells to E2-treated HUVEC (by up to 40 %).
  
  
  CONCLUSIONS
  Estrogen might functionally down-regulates GROalpha expression through estrogen receptor alpha on endothelial cells.
authors.affiliation: Department of Cardiology, General Hospital of Jinan Military Region, Jinan 250031, China. leizhubin88@email.com.cn
authors.forename: Z B
authors.initials: ZB
authors.lastname: Lei
authors.forename: X Y
authors.initials: XY
authors.lastname: Li
authors.forename: B C
authors.initials: BC
authors.lastname: Wang
authors.forename: Y F
authors.initials: YF
authors.lastname: Yang
authors.forename: N Z
authors.initials: NZ
authors.lastname: You
authors.forename: J
authors.initials: J
authors.lastname: Sun
mesh_terms: D002478:Cells, Cultured; D054360:Chemokine CXCL1; D018925:Chemokines / Q000096:biosynthesis* / Q000235:genetics; D019743:Chemokines, CXC; D002630:Chemotactic Factors / Q000096:biosynthesis* / Q000235:genetics; D015536:Down-Regulation; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D004958:Estradiol / Q000494:pharmacology*; D005786:Gene Expression Regulation / Q000187:drug effects*; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000096:biosynthesis* / Q000235:genetics; D012333:RNA, Messenger / Q000096:biosynthesis / Q000187:drug effects / Q000235:genetics; D011960:Receptors, Estrogen / Q000037:antagonists & inhibitors; D013629:Tamoxifen / Q000494:pharmacology; D014471:Umbilical Veins / Q000166:cytology
chemical_list: C475829:CXCL1 protein, human; D054360:Chemokine CXCL1; D018925:Chemokines; D019743:Chemokines, CXC; D002630:Chemotactic Factors; D036341:Intercellular Signaling Peptides and Proteins; D012333:RNA, Messenger; D011960:Receptors, Estrogen; D013629:Tamoxifen; D004958:Estradiol